Pervasive translation in Mycobacterium tuberculosis

  1. Carol Smith
  2. Jill G Canestrari
  3. Archer J Wang
  4. Matthew M Champion
  5. Keith M Derbyshire  Is a corresponding author
  6. Todd A Gray  Is a corresponding author
  7. Joseph T Wade  Is a corresponding author
  1. New York State Department of Health, United States
  2. University of Notre Dame, United States

Abstract

Most bacterial ORFs are identified by automated prediction algorithms. However, these algorithms often fail to identify ORFs lacking canonical features such as a length of >50 codons or the presence of an upstream Shine-Dalgarno sequence. Here, we use ribosome profiling approaches to identify actively translated ORFs in Mycobacterium tuberculosis. Most of the ORFs we identify have not been previously described, indicating that the M. tuberculosis transcriptome is pervasively translated. The newly described ORFs are predominantly short, with many encoding proteins of ≤50 amino acids. Codon usage of the newly discovered ORFs suggests that most have not been subject to purifying selection, and hence are unlikely to contribute to cell fitness. Nevertheless, we identify 90 new ORFs (median length of 52 codons) that bear the hallmarks of purifying selection. Thus, our data suggest that pervasive translation of short ORFs in Mycobacterium tuberculosis serves as a rich source for the evolution of new functional proteins.

Data availability

Raw Illumina sequencing data are available from the ArrayExpress and European Nucleotide Archive repositories with accession numbers E-MTAB-8039 and E-MTAB-10695. Raw mass spectrometry data are available through MassIVE, with exchange #MSV000087541. Reviewers can access the raw mass spectrometry data at ftp://MSV000087541@massive.ucsd.edu, password: sproteinTBPython code is available at https://github.com/wade-lab/Mtb_Ribo-RET.

The following data sets were generated

Article and author information

Author details

  1. Carol Smith

    Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, United States
    Competing interests
    No competing interests declared.
  2. Jill G Canestrari

    Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, United States
    Competing interests
    No competing interests declared.
  3. Archer J Wang

    Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, United States
    Competing interests
    No competing interests declared.
  4. Matthew M Champion

    Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, United States
    Competing interests
    No competing interests declared.
  5. Keith M Derbyshire

    Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, United States
    For correspondence
    keith.derbyshire@health.ny.gov
    Competing interests
    No competing interests declared.
  6. Todd A Gray

    Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, United States
    For correspondence
    todd.gray@health.ny.gov
    Competing interests
    No competing interests declared.
  7. Joseph T Wade

    Wadsworth Center, Division of Genetics, New York State Department of Health, Albany, United States
    For correspondence
    joseph.wade@gmail.com
    Competing interests
    Joseph T Wade, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9779-3160

Funding

National Institute of Allergy and Infectious Diseases (R21AI117158)

  • Keith M Derbyshire
  • Todd A Gray
  • Joseph T Wade

National Institute of Allergy and Infectious Diseases (R21AI119427)

  • Keith M Derbyshire
  • Todd A Gray
  • Joseph T Wade

National Institute of General Medical Sciences (R01GM139277)

  • Matthew M Champion
  • Keith M Derbyshire
  • Todd A Gray
  • Joseph T Wade

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,738
    views
  • 471
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Carol Smith
  2. Jill G Canestrari
  3. Archer J Wang
  4. Matthew M Champion
  5. Keith M Derbyshire
  6. Todd A Gray
  7. Joseph T Wade
(2022)
Pervasive translation in Mycobacterium tuberculosis
eLife 11:e73980.
https://doi.org/10.7554/eLife.73980

Share this article

https://doi.org/10.7554/eLife.73980

Further reading

    1. Microbiology and Infectious Disease
    Louise Tzung-Harn Hsieh, Belinda S Hall ... Rachel E Simmonds
    Research Article

    The drivers of tissue necrosis in Mycobacterium ulcerans infection (Buruli ulcer disease) have historically been ascribed solely to the directly cytotoxic action of the diffusible exotoxin, mycolactone. However, its role in the clinically evident vascular component of disease aetiology remains poorly explained. We have now dissected mycolactone’s effects on human primary vascular endothelial cells in vitro. We show that mycolactone-induced changes in endothelial morphology, adhesion, migration, and permeability are dependent on its action at the Sec61 translocon. Unbiased quantitative proteomics identified a profound effect on proteoglycans, driven by rapid loss of type II transmembrane proteins of the Golgi, including enzymes required for glycosaminoglycan (GAG) synthesis, combined with a reduction in the core proteins themselves. Loss of the glycocalyx is likely to be of particular mechanistic importance, since knockdown of galactosyltransferase II (beta-1,3-galactotransferase 6; B3GALT6), the GAG linker-building enzyme, phenocopied the permeability and phenotypic changes induced by mycolactone. Additionally, mycolactone depleted many secreted basement membrane components and microvascular basement membranes were disrupted in vivo during M. ulcerans infection in the mouse model. Remarkably, exogenous addition of laminin-511 reduced endothelial cell rounding, restored cell attachment and reversed the defective migration caused by mycolactone. Hence supplementing mycolactone-depleted extracellular matrix may be a future therapeutic avenue, to improve wound healing rates.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Ana Patrícia Graça, Vadim Nikitushkin ... Gerald Lackner
    Research Article

    Mycofactocin is a redox cofactor essential for the alcohol metabolism of mycobacteria. While the biosynthesis of mycofactocin is well established, the gene mftG, which encodes an oxidoreductase of the glucose-methanol-choline superfamily, remained functionally uncharacterized. Here, we show that MftG enzymes are almost exclusively found in genomes containing mycofactocin biosynthetic genes and are present in 75% of organisms harboring these genes. Gene deletion experiments in Mycolicibacterium smegmatis demonstrated a growth defect of the ∆mftG mutant on ethanol as a carbon source, accompanied by an arrest of cell division reminiscent of mild starvation. Investigation of carbon and cofactor metabolism implied a defect in mycofactocin reoxidation. Cell-free enzyme assays and respirometry using isolated cell membranes indicated that MftG acts as a mycofactocin dehydrogenase shuttling electrons toward the respiratory chain. Transcriptomics studies also indicated remodeling of redox metabolism to compensate for a shortage of redox equivalents. In conclusion, this work closes an important knowledge gap concerning the mycofactocin system and adds a new pathway to the intricate web of redox reactions governing the metabolism of mycobacteria.